- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 699
Advisorymandi accepts $36m from EST
The financial advisory services provider plans to use EST's investment to launch a financial education arm and build a multilingual investment platform.
Sep 6, 2019Sourcewater filters through $7.2m
Oilfield water management company Sourcewater secured series A funding from backers including Marubeni and Bison having launched from MIT’s Energy Ventures program in 2014.
Sep 6, 2019T-Rex collects $15m
Citi co-led a $15m round for the investment risk management software producer that also featured returning investor Innogy.
Sep 5, 2019Neura lures corporates to $16m series B
The app engagement software developer raised the funding in a Liberty Technology Venture Capital-led round featuring Amdocs and existing investor Axa.
Sep 5, 2019Passage Bio packs in another $110m
University of Pennsylvania-allied CNS disease therapy developer Passage Bio lured contributions from investors including Lilly Asia Ventures, which also featured in its $116m series A earlier this year.
Sep 5, 2019Federated Wireless connects to $51m series C
The telecommunications spectrum provider has now raised $120m altogether, SBA Communications and American Tower contributing to its latest round.
Sep 5, 2019Cartica AI clinches series B funding
Cartica AI, an autonomous perception tech developer forged from Technion spinout Cortica, secured capital from OurCrowd, Continental, Toyota and BMW in what appears to be its first publicly-disclosed round.
Sep 5, 2019Ginger jumps to $35m series C
MIT Media Lab spinout Ginger has raised $35m as it looks to further develop its mental and emotional health support app.
Sep 5, 2019Juul's convertible debt round reaches $785m
Altria-backed e-cigarette brand Juul has added $460m to a convertible note round it plans to close at $800m according to a securities filing.
Sep 5, 2019Nkarta inks $114m series B deal
Nkarta, which is developing cell therapy treatments for cancer, has emerged from stealth with $114m in a round featuring Novo, Amgen Ventures and SR One.
Sep 5, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


